News

Analysts anticipate Exact Sciences to report an earnings per share (EPS) of $0.02. Anticipation surrounds Exact Sciences's ...
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) will be reporting earnings this Wednesday after market close.
Based on the findings, the biggest changes happened between the ages of 45 and 55. During this time, many of the tissues ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...
University research in Wisconsin led to $500 million Third Wave business, screening tests for cancer, including Cologuard ...
Exact Sciences Corporation (NASDAQ:EXAS) is one of the best mid cap pharma stocks to buy. On July 9, Exact Sciences announced ...
In fact, eight times out of ten, EXAS stock has popped higher in the week following the flashing of the 2-8-D sequence, with a median return of 4.91%. It’s possible, then, that within a week or two, ...
Exact Sciences Corporation's (NASDAQ:EXAS) first quarter revenue experienced 11% rise on reported and core basis exceeding the mid pint of guidance over $19 million.
The recognition is based on a confidential survey of employees around the world, offering an independent assessment of Exact Sciences’ culture, work environment, and leadership. This year, 77% of ...
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $707 million for the first quarter ended ...